Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories

Dr Reddys Laboratories

BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Oct 18, 16:00
2721.25
-5.4 (-0.2%)
VOLUME 4,488
LIVE
NSE
Oct 18, 15:55
2724.85
-2.55 (-0.09%)
VOLUME 289,279
News on Dr Reddys Laboratories
Select Year: 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Dr. Reddy’s Q2 PAT may dip 10% YoY to Rs. 455.9 cr: Emkay

3.56 pm | 14 Oct 2019 |  Source: Moneycontrol.com

Net Sales are expected to increase by 9.7 percent Y-o-Y (up 8.4 percent Q-o-Q) to Rs. 4,167.1 crore, according to Emkay....

USFDA issues Establishment Inspection Report for Dr Reddy's Bollaram plant

12.03 pm | 06 Oct 2019 |  Source: Moneycontrol.com

The receipt of EIR indicated closure of the audit of the Bollaram facility...

Ranitidine controversy: Which Indian pharma companies stand to lose?

2.12 pm | 30 Sep 2019 |  Source: Moneycontrol.com

NULL...

Dr Reddy's launches heartburn capsules in US market

5.26 pm | 16 Sep 2019 |  Source: PTI

The company has launched Lansoprazole delayed-release capsules USP in the strength of 15 mg in the US market, as approved by the United States Food an...

Stocks in the news: Dr Reddy's Labs, PNB, SBI, PVR, Oriental Bank, DHFL, L&T Finance

8.09 am | 13 Sep 2019 |  Source: Moneycontrol.com

Dr Reddy's Labs | PNB | State Bank of India | PVR | Oriental Bank of Commerce | DHFL | L&T Finance Holdings are the stocks which are in news today...

Dr Reddys launches generic Emend in US market

7.51 am | 12 Sep 2019 |  Source: PTI

Fosaprepitant is used with other medications to help prevent nausea and vomiting caused by chemotherapy. The launch follows the approval by the US Foo...

Buy Dr. Reddy’s Labs; target of Rs 3360: HDFC Securities

11.23 am | 31 Jul 2019 |  Source: Moneycontrol.com

HDFC Securities is bullish on Dr. Reddy’s Labs has recommended buy rating on the stock with a target price of Rs 3360 in its research report dated J...

Accumulate Dr. Reddy's Laboratories; target of Rs 2997: Prabhudas Lilladher

11.22 am | 31 Jul 2019 |  Source: Moneycontrol.com

Prabhudas Lilladher recommended accumulate rating on Dr. Reddy's Laboratories with a target price of Rs 2997 in its research report dated July 29,...

Dr Reddys Labs Standalone June 2019 Net Sales at Rs 2,508.70 crore, down 4.16% Y-o-Y

4.52 pm | 29 Jul 2019 |  Source: Moneycontrol.com

NULL...

Dr. Reddy’s Laboratories Q1 PAT seen up 13.6% YoY to Rs. 540.8 cr: Prabhudas Lilladher

4.50 pm | 12 Jul 2019 |  Source: Moneycontrol.com

Net Sales are expected to increase by 2.2 percent Y-o-Y (down 5.2 percent Q-o-Q) to Rs. 3,820.3 crore, according to Prabhudas Lilladher....

Dr Reddys Labs Standalone March 2019 Net Sales at Rs 2,645.20 crore, up 6.13% Y-o-Y

3.50 pm | 17 May 2019 |  Source: Moneycontrol.com

NULL...

Dr Reddys Labs Consolidated March 2019 Net Sales at Rs 4,029.60 crore, up 13.39% Y-o-Y

3.50 pm | 17 May 2019 |  Source: Moneycontrol.com

NULL...

Dr Reddy’s Q4 net up 44% YoY at Rs 434cr

3.33 pm | 17 May 2019 |  Source: Moneycontrol.com

Revenue rose 14 percent YoY to Rs 4,016.6 crore....

Dr Reddy's Q4 preview: Profit to rise 37% YoY to Rs 413cr; EBITDA margin may touch 23%

9.27 am | 17 May 2019 |  Source: Moneycontrol.com

Narnolia Financial Advisors expects the pharma company to report a net profit of Rs 545 crore as against Rs 500 crore in the last quarter...

1 2
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.